Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

Nurix Therapeutics Q3 EPS $(1.03) Misses $(0.88) Estimate, Sales $7.894M Miss $16.736M Estimate

Author: Benzinga Newsdesk | October 09, 2025 03:03pm

Posted In: NRIX

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist